Heron Therapeutics, Inc.HRTXNASDAQ
LOADING
|||
Revenue Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
2.72%
↓ 82% below average
Average (39q)
15.05%
Historical baseline
Range
High:183.97%
Low:-27.60%
Volatility
1406.2%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 2.72% |
| Q2 2025 | -4.38% |
| Q1 2025 | -4.61% |
| Q4 2024 | 24.29% |
| Q3 2024 | -8.92% |
| Q2 2024 | 3.91% |
| Q1 2024 | 1.28% |
| Q4 2023 | 8.90% |
| Q3 2023 | -1.03% |
| Q2 2023 | 7.25% |
| Q1 2023 | -1.38% |
| Q4 2022 | 13.07% |
| Q3 2022 | -3.88% |
| Q2 2022 | 17.79% |
| Q1 2022 | 13.57% |
| Q4 2021 | -11.08% |
| Q3 2021 | 3.51% |
| Q2 2021 | 12.11% |
| Q1 2021 | -2.85% |
| Q4 2020 | 3.21% |
| Q3 2020 | -11.92% |
| Q2 2020 | -10.76% |
| Q1 2020 | -27.60% |
| Q4 2019 | -17.69% |
| Q3 2019 | 16.27% |
| Q2 2019 | 16.00% |
| Q1 2019 | 9.56% |
| Q4 2018 | 45.78% |
| Q3 2018 | 14.52% |
| Q2 2018 | 49.36% |
| Q1 2018 | 15.06% |
| Q4 2017 | 17.28% |
| Q3 2017 | 0.73% |
| Q2 2017 | 134.31% |
| Q1 2017 | 183.97% |
| Q4 2016 | 93.49% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |